3,5-diiodothyropropionic acid and Chronic Disease

3,5-diiodothyropropionic acid has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anand, I; Barnhill, JG; Churby, L; Dunlap, M; Edson, RG; Erikson, J; Goldman, S; Hattler, B; Ladenson, PW; McCarren, M; Morkin, E; O'Brien, T; Shih, MC; Thai, H; Warner, A; Warren, SR	1

Trials

1 trial(s) available for 3,5-diiodothyropropionic acid and Chronic Disease

Article	Year
Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study. The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:3 Topics: Aged; Body Mass Index; Body Weight; Chronic Disease; Diiodothyronines; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Humans; Lipoproteins; Middle Aged; Osteogenesis; Patient Selection; Pilot Projects; Propionates; Prospective Studies; Thyrotropin; Thyroxine; Time Factors; Treatment Outcome; Triiodothyronine	2010

Article

Year

Effects of the thyromimetic agent diiodothyropropionic acid on body weight, body mass index, and serum lipoproteins: a pilot prospective, randomized, controlled study.

The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:3

Topics: Aged; Body Mass Index; Body Weight; Chronic Disease; Diiodothyronines; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Humans; Lipoproteins; Middle Aged; Osteogenesis; Patient Selection; Pilot Projects; Propionates; Prospective Studies; Thyrotropin; Thyroxine; Time Factors; Treatment Outcome; Triiodothyronine

2010